Home - X4 Pharmaceuticals

With grit and integrity, we advance novel therapies for individuals with chronic neutropenic disorders. The page tagline says, “Progress for Patients” over an image of the sun rising behind Half Dome in Yosemite National Park. There is a button to "learn more" that directs to the website’s Focus page.

PROGRESS

PATIENTS

Enabling a better future for people with rare immune disorders

recent news

X4 Pharmaceuticals and taiba rare Announce Exclusive Agreement for the Distribution and Commercialization of XOLREMDI® (mavorixafor) in WHIM Syndrome in Select Middle East Countries
February 19, 2025
X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia
February 6, 2025
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 3, 2025

© Copyright 2025 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics